CN106749422B - 四苯基卟啉芳基钌化合物及其制备方法和用途 - Google Patents
四苯基卟啉芳基钌化合物及其制备方法和用途 Download PDFInfo
- Publication number
- CN106749422B CN106749422B CN201611046003.4A CN201611046003A CN106749422B CN 106749422 B CN106749422 B CN 106749422B CN 201611046003 A CN201611046003 A CN 201611046003A CN 106749422 B CN106749422 B CN 106749422B
- Authority
- CN
- China
- Prior art keywords
- tetraphenylporphyrin
- ruthenium compound
- aryl ruthenium
- aryl
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- -1 Tetraphenylporphyrin aryl ruthenium compound Chemical class 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000003814 drug Substances 0.000 claims abstract description 8
- 229940079593 drug Drugs 0.000 claims abstract description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 24
- 150000003222 pyridines Chemical class 0.000 claims description 15
- YNHJECZULSZAQK-UHFFFAOYSA-N tetraphenylporphyrin Chemical compound C1=CC(C(=C2C=CC(N2)=C(C=2C=CC=CC=2)C=2C=CC(N=2)=C(C=2C=CC=CC=2)C2=CC=C3N2)C=2C=CC=CC=2)=NC1=C3C1=CC=CC=C1 YNHJECZULSZAQK-UHFFFAOYSA-N 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 6
- 238000001556 precipitation Methods 0.000 claims description 6
- 229910052707 ruthenium Inorganic materials 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- YKFLAYDHMOASIY-UHFFFAOYSA-N γ-terpinene Chemical compound CC(C)C1=CCC(C)=CC1 YKFLAYDHMOASIY-UHFFFAOYSA-N 0.000 claims description 6
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 claims description 5
- 239000013078 crystal Substances 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 238000010992 reflux Methods 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims 2
- XILYOLONIFWGMT-UHFFFAOYSA-N benzene;dihydrochloride Chemical compound Cl.Cl.C1=CC=CC=C1 XILYOLONIFWGMT-UHFFFAOYSA-N 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 abstract description 5
- 201000011510 cancer Diseases 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 3
- 239000002775 capsule Substances 0.000 abstract description 2
- 239000000839 emulsion Substances 0.000 abstract description 2
- 238000002347 injection Methods 0.000 abstract description 2
- 239000007924 injection Substances 0.000 abstract description 2
- 239000006187 pill Substances 0.000 abstract description 2
- 239000000375 suspending agent Substances 0.000 abstract description 2
- 239000003826 tablet Substances 0.000 abstract description 2
- WWRCMNKATXZARA-UHFFFAOYSA-N 1-Isopropyl-2-methylbenzene Chemical compound CC(C)C1=CC=CC=C1C WWRCMNKATXZARA-UHFFFAOYSA-N 0.000 description 6
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 5
- 239000000460 chlorine Substances 0.000 description 5
- 229910052801 chlorine Inorganic materials 0.000 description 5
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 5
- YAYGSLOSTXKUBW-UHFFFAOYSA-N ruthenium(2+) Chemical compound [Ru+2] YAYGSLOSTXKUBW-UHFFFAOYSA-N 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 229910052697 platinum Inorganic materials 0.000 description 4
- ODLMAHJVESYWTB-UHFFFAOYSA-N propylbenzene Chemical compound CCCC1=CC=CC=C1 ODLMAHJVESYWTB-UHFFFAOYSA-N 0.000 description 4
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 206010034133 Pathogen resistance Diseases 0.000 description 2
- 206010034972 Photosensitivity reaction Diseases 0.000 description 2
- 239000012327 Ruthenium complex Substances 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229960004756 ethanol Drugs 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 208000007578 phototoxic dermatitis Diseases 0.000 description 2
- 231100000018 phototoxicity Toxicity 0.000 description 2
- 150000004032 porphyrins Chemical class 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- KLDKFEPHKRXRRH-UHFFFAOYSA-N [Ru+2].[Cl+] Chemical compound [Ru+2].[Cl+] KLDKFEPHKRXRRH-UHFFFAOYSA-N 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000002895 emetic Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0046—Ruthenium compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
细胞株 | A2780(避光) | A2780(光照) |
IC<sub>50</sub>(umol/mL) | 8.0±1.5 | 1.2±0.2 |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611046003.4A CN106749422B (zh) | 2016-11-22 | 2016-11-22 | 四苯基卟啉芳基钌化合物及其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611046003.4A CN106749422B (zh) | 2016-11-22 | 2016-11-22 | 四苯基卟啉芳基钌化合物及其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106749422A CN106749422A (zh) | 2017-05-31 |
CN106749422B true CN106749422B (zh) | 2019-01-29 |
Family
ID=58974112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611046003.4A Active CN106749422B (zh) | 2016-11-22 | 2016-11-22 | 四苯基卟啉芳基钌化合物及其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106749422B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101851256A (zh) * | 2010-04-30 | 2010-10-06 | 广东药学院 | 一种以柔性碳链联接的钌(ⅱ)卟啉配合物及其制备方法和应用 |
CN103724362A (zh) * | 2013-12-30 | 2014-04-16 | 重庆大学 | 对苯二甲酸桥联分子钳系列卟啉化合物及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN204602710U (zh) * | 2015-04-28 | 2015-09-02 | 绵阳九天磁材有限公司 | 一种软磁铁氧体磁芯生产去毛边装置 |
-
2016
- 2016-11-22 CN CN201611046003.4A patent/CN106749422B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101851256A (zh) * | 2010-04-30 | 2010-10-06 | 广东药学院 | 一种以柔性碳链联接的钌(ⅱ)卟啉配合物及其制备方法和应用 |
CN103724362A (zh) * | 2013-12-30 | 2014-04-16 | 重庆大学 | 对苯二甲酸桥联分子钳系列卟啉化合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN106749422A (zh) | 2017-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104402939A (zh) | 一种铱金属配合物及其制备方法和用途 | |
CN104402940A (zh) | 一种铑配合物及其制备方法和用途 | |
CN106632494B (zh) | 卟啉芳基钌配合物及其制备方法和用途 | |
Qi et al. | Synthesis, structure and anticancer studies of Cu (Ⅱ) and Ni (Ⅱ) complexes based on 2-hydroxy-1-naphthaldehyde-4-aminoantipyrine Schiff-base | |
CN102964387B (zh) | 一种有机金属钌离子对化合物及其制备方法和用途 | |
CN106749422B (zh) | 四苯基卟啉芳基钌化合物及其制备方法和用途 | |
Li et al. | An AIE-featured triphenyltin (IV)-triphenylamine acylhydrazone compound and anticancer application | |
CN106588995B (zh) | 酞菁-芳基钌化合物及其制备方法和用途 | |
CN106674286B (zh) | 四苯基卟啉乙醚芳基钌化合物及制备方法和用途 | |
CN106632493B (zh) | 四苯基卟啉连二胺芳基钌化合物及其制备方法和用途 | |
CN102964385B (zh) | 一种有机金属钌化合物及其制备方法和用途 | |
CN106588939B (zh) | 酞菁-芳基钌化合物及其制备方法和用途 | |
CN106588994B (zh) | 酞菁芳基钌配合物及其制备方法和用途 | |
CN106588996B (zh) | 酞菁芳基钌配合物及其制备方法和用途 | |
Yang et al. | Synthesis, characterization and cell imaging properties of rare earth compounds based on hydroxamate ligand | |
CN103288881B (zh) | 一种具有抗肿瘤活性的双核金属钌配合物 | |
CN103288880B (zh) | 一种具有抗肿瘤活性的半三明治型双核有机金属钌化合物 | |
CN104370971A (zh) | 一种氰基乙烯基钌化合物及其制备方法和用途 | |
CN1970543A (zh) | 具有抗癌活性作为备选药物的系列离子液体的合成及应用 | |
CN104478939B (zh) | 一种金属铑化合物及其制备方法和用途 | |
CN104370969A (zh) | 一种钌化合物及其制备方法和用途 | |
CN107417734B (zh) | 一种具有双光子吸收特性的铂配合物及其制备方法和应用 | |
CN101205244B (zh) | 一种双金属七核抗癌化合物及其制备方法和应用 | |
CN101492539B (zh) | 二氯聚天冬氨酸铂 | |
CN107501305B (zh) | 一种达沙替尼-铜(ii)配合物及其合成方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP01 | Change in the name or title of a patent holder |
Address after: Mingxiu Road East of Nanning city the Guangxi Zhuang Autonomous Region 530001 Guangxi Teachers Education University No. 175 Patentee after: NANNING NORMAL University Address before: Mingxiu Road East of Nanning city the Guangxi Zhuang Autonomous Region 530001 Guangxi Teachers Education University No. 175 Patentee before: Guangxi Normal University |
|
CP01 | Change in the name or title of a patent holder | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191115 Address after: 210000 No.1, Xiushan Middle Road, Lishui Economic Development Zone, Nanjing City, Jiangsu Province Patentee after: NANJING ADVANCED BIOMATERIALS AND PROCESS EQUIPMENT RESEARCH INSTITUTE Co.,Ltd. Address before: Mingxiu Road East of Nanning city the Guangxi Zhuang Autonomous Region 530001 Guangxi Teachers Education University No. 175 Patentee before: Nanning Normal University |
|
TR01 | Transfer of patent right |